Independent & educational platform Not a government body. No link or affiliation with any government organisation. Made for learning only. Test only systems you own or are authorised to test. Become a Partner or Sponsor → Full disclaimer

CVE-2025-60298

medium

Novel-Plus up to 5.2.4 was discovered to contain a Stored Cross-Site Scripting (XSS) vulnerability via the /author/updateIndexName endpoint.

Vendor / product: Xxyopen — novel-plus

Novel-Plus up to 5.2.4 was discovered to contain a Stored Cross-Site Scripting (XSS) vulnerability via the /author/updateIndexName endpoint. This vulnerability allows authenticated attackers to inject malicious JavaScript code through the indexName parameter, which gets stored in the database and executed when other users view the affected book chapter.

CVSS
5.4
5.4 (CVSS v3.1)
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Severity source: NVD CVSS v3.1 (134c704f-9b21-4f2e-91b3-4a467353bcc0)
Timeline (UTC)
Published: 2025-10-08 13:15
Modified: 2026-11-05 22:10
NVD status: Analyzed
Last synced 1 week ago
Verified against the source API 2026-11-05 22:23 UTC
Exploitation
Not listed in CISA KEV (as of last catalog sync)
Absence from KEV does not mean a CVE is not exploited. Exploitation status: unknown (no authoritative evidence in our sources).

Affected products

xxyopen / novel-plus ≤5.2.4

Weakness classification (CWE)

Source: NVD / CISA. “NVD-CWE-Other” and “NVD-CWE-noinfo” mean NVD could not assign a specific weakness.

Mitigation & advisories

No vendor advisory or patch reference tagged by NVD. Check the references below.

References

Data sources

NVD CVE API 2.0 — fetched 2026-11-05 22:23 UTC · record ↗

Learn the basics

Understanding CVEs and CVSS Scores

Related CVEs